Edit Record #19
Back to List
Patient / Body Info
Body Part
*
Clinical Details
Symptoms & Signs
Psychiatric evaluation, various mental health conditions
Disease / Diagnosis
Psychiatry OP Drug Reference (28/12/25)
Tests to be Done
Test Findings / Report
Treatment
Medicine
Risperidone Olanzapine Haloperidol Chlorpromazine Trihexyphenidyl Quetiapine Fluoxetine Escitalopram Imipramine Amitriptyline Sertraline Lorazepam Diazepam Nitrazepam Alprazolam Clonazepam Chlordiazepoxide Propranolol Sodium Valproate Carbamazepine Lithium Levothyroxine (Eltroxin) B-Complex (BCT) Multivitamin (MVT) Calcium tablet
Class
Dose
Frequency
Duration
Injection Required
— Select —
Yes
No
Additional Notes
Others
Psychiatry OP prescription reference dated 28/12/2025.
Doctor's Notes
Key monitoring notes: — Risperidone: EPS at higher doses, hyperprolactinemia — Olanzapine: high risk of diabetes and dyslipidemia — Haloperidol: severe EPS, tardive dyskinesia risk — Quetiapine: sedation, weight gain, QT prolongation — Lithium: requires regular serum levels, renal and thyroid monitoring — Carbamazepine: risk of agranulocytosis, Stevens-Johnson syndrome — Sodium Valproate: hepatotoxicity, teratogenic — avoid in pregnancy — Propranolol: contraindicated in asthma/COPD; masks hypoglycemia in diabetics — Lorazepam: preferred in liver disease (no active metabolites) — Fluoxetine: long half-life, fewer withdrawal symptoms
Images
Upload additional images
JPG · PNG · GIF · WEBP — max 5 MB each
Update Record
Cancel